Saralasin API Manufacturers
compare suppliers & get competitive offers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Saralasin API 34273-10-4?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Saralasin. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Saralasin
- Synonyms:
- Cas Number:
- 34273-10-4
- DrugBank number:
- DB06763
- Unique Ingredient Identifier:
- H2AFV2HE66
General Description:
Saralasin is a chemical compound identified by the CAS number 34273-10-4. It is known for its distinct pharmacological properties and applications.
Categories:
Saralasin is categorized under the following therapeutic classes: Agents Acting on the Renin-Angiotensin System, Agents causing hyperkalemia, Agents that produce hypertension, Amino Acids, Peptides, and Proteins, Angiotensin Receptor Antagonists, Angiotensins, Autacoids, Biological Factors, Inflammation Mediators, Oligopeptides, Peptides. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.
Saralasin is a type of Antihypertensive agents
Antihypertensive agents are a crucial category of pharmaceutical active pharmaceutical ingredients (APIs) used to treat high blood pressure, also known as hypertension. These medications are designed to lower blood pressure and reduce the risk of associated cardiovascular complications.
Antihypertensive agents function by targeting various mechanisms involved in blood pressure regulation. Some common classes of antihypertensive agents include angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), beta-blockers, calcium channel blockers (CCBs), and diuretics.
ACE inhibitors work by inhibiting the enzyme responsible for converting angiotensin I to angiotensin II, a hormone that constricts blood vessels. ARBs, on the other hand, block the receptors to which angiotensin II binds, thereby preventing its vasoconstrictive effects.
Beta-blockers reduce blood pressure by blocking the effects of adrenaline and noradrenaline, which are responsible for increasing heart rate and constricting blood vessels. CCBs inhibit calcium from entering the smooth muscles of blood vessels, resulting in relaxation and vasodilation. Diuretics promote the elimination of excess fluid and sodium from the body, reducing blood volume and thereby lowering blood pressure.
Antihypertensive agents are typically prescribed based on the individual patient's condition and specific needs. They can be used alone or in combination to achieve optimal blood pressure control. It is important to note that antihypertensive agents should be taken regularly as prescribed by a healthcare professional and may require periodic monitoring to ensure their effectiveness and manage any potential side effects.
In summary, antihypertensive agents play a vital role in the management of hypertension by targeting various mechanisms involved in blood pressure regulation. These medications offer significant benefits in reducing the risk of cardiovascular complications associated with high blood pressure.
